New patent for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF

Annual Drug Patent Expirations for FLONASE+SENSIMIST+ALLERGY+RELIEF Flonase Sensimist Allergy Relief is a drug marketed by Glaxosmithkline Cons and is included in one NDA. It is available from two suppliers. There…

The post New patent for Glaxosmithkline Cons drug FLONASE SENSIMIST ALLERGY RELIEF appeared first on DrugPatentWatch - Make Better Decisions.


Comments are closed.

Biotechblog